| vaccinatie met alleen virusachtige deeltjes tegen 'Severe acute respiratory syndrome'-coronavirus 2 (verrichting) |
| vaccinatie met virusachtige deeltjes tegen SARS-CoV-2 |
| toedienen van VLP-vaccin tegen COVID-19
vaccinatie met alleen virusachtige deeltjes tegen 'Severe acute respiratory syndrome'-coronavirus 2
toedienen van 'virus-like particles'-vaccin tegen SARS-CoV-2
|
| Administration of SARS-CoV-2 virus-like particle antigen vaccine |
| 2019-nCoV virus-like particle antigen immunization
2019 novel coronavirus virus-like particle antigen immunization
COVID-19 virus-like particle antigen immunization
COVID-19 virus-like particle antigen vaccination
Severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccination
SARS-CoV-2 virus-like particle antigen immunization
SARS-CoV-2 virus-like particle antigen vaccination
2019-nCoV virus-like particle antigen vaccination
2019 novel coronavirus virus-like particle antigen vaccination
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen
|
